CONTACT US   |  (864) 397-5101

SHL Medical further strengthens vertical capabilities with the acquisition of US manufacturer Superior Tooling Inc.

Courtesy of SHL Medical

Continuing its ambitious growth journey, SHL Medical has acquired Superior Tooling Inc., a US-based manufacturing company specializing in plastic injection molds. The integration of Superior Tooling will strengthen the SHL’s inhouse manufacturing capabilities, particularly for its upcoming US manufacturing site in North Charleston, SC, scheduled to begin operations in mid-2024.

SHL Medical (hereinafter referred to as “SHL”), a world-leading provider of advanced drug delivery solutions headquartered in Switzerland, proudly announces the acquisition of Superior Tooling Inc., a US manufacturer of plastic injection molds through quality tooling, based in Wake Forest, North Carolina.

With two new manufacturing sites underway in North Charleston, SC, USA, and Zug, Switzerland, complementing the existing facilities in Taiwan, SHL strategically addresses the growing demand in the autoinjector market.  Superior Tooling will support SHL’s strategic manufacturing operations globally, especially strengthening its vertical capabilities for the new site in North Charleston, while solidifying its local presence. This expansion of strengths underlines SHL’s global strategy, emphasizing one of its distinctive features – full in-house manufacturing – and positions tooling as one of SHL’s core competencies close to the new manufacturing site in South Carolina.

Ulrich Faessler, Chairman and CEO of SHL Medical, looks forward to the collaboration: “The demand for our autoinjectors, including treatment areas such as diabetes and weight management, is growing rapidly. Through continuous advancements and dedication, we deliver on our strategic vision to uphold our position as market leaders. This acquisition marks a significant milestone in our journey towards globalizing our operations to better serve our customer base. We are happy to welcome Superior Tooling into the SHL family.”

Expanding tooling capabilities globally

The acquisition of Superior Tooling not only supports the tooling needs of SHL’s in-house manufacturing but also its strategy to deliver the highest quality tools to customers across industries. The US company will work closely with SHL’s existing tooling departments to develop new solutions for its global customer base.

“This marks a significant step forward for our potential and growth trajectory. We take great pride in having our capabilities recognized by a global player, and eagerly look forward to maximizing them as integral members of SHL Medical. I am confident that the synergies between our capabilities and SHL’s established tooling expertise will prove highly advantageous for both our existing and new customers,” expresses Robbie Earnhardt, President of Superior Tooling.

New manufacturing site in North Charleston, NC, USA

Join now to enjoy expanded member benefits!

Enjoy exclusive member content, special events, savings, networking and more

Tamia Sumpter

Tamia is a driven senior undergraduate Bioengineering student currently enrolled at Clemson University. With a strong foundation in her field, she has honed her skills through hands-on experience in research and development at Eli Lilly & Company. During her time in the ADME department, Tamia contributed significantly by working on siRNAs and their applications in finding In Vitro-In Vivo Correlation (IVIVC). Looking ahead, Tamia has set her sights on a promising career in law. She aspires to specialize in Intellectual Property Law, with a particular focus on serving as in-house counsel for leading medical device or pharmaceutical companies. Her enthusiasm for this role is palpable as she prepares to embark on her legal journey! She is also a proud member of the Omicron Phi chapter of Delta Sigma Theta Sorority, Inc., PEER Mentor for Clemson PEER/WiSE, and currently serves as the President of Clemson Bioengineering Organization (CBO). With her unique blend of scientific knowledge and legal interests, Tamia is poised to make a meaningful impact in the healthcare and life sciences industries.